Variation at the Hepatic Lipase and Apolipoprotein AI/CIII/AIV Loci is a Major Cause of Genetically Determined Variation in Plasma HDL Cholesterol Levels

Overview

Journal J Clin Invest

Specialty General Medicine

Date 1994 Dec 1

PMID 7989594

Citations 29

Authors

J C Cohen

Z Wang

S M Grundy

M R Stoesz

R Guerra

Affiliations

Soon will be listed here.

Abstract

Genetic factors have been shown to play an important role in determining interindividual variation in plasma HDL-C levels, but the specific genetic determinants of HDL cholesterol (HDL-C) levels have not been elucidated. In this study, the effects of variation in the genomic regions encoding hepatic lipase, apolipoprotein AI/CIII/AIV, and the cholesteryl ester transfer protein on plasma HDL-C levels were examined in 73 normotriglyceridemic, Caucasian nuclear families. Genetic factors accounted for 56.5 +/- 13% of the interindividual variation in plasma HDL-C levels. For each candidate gene, adjusted plasma HDL-C levels of sibling pairs who shared zero, one, or two parental alleles identical-by-descent were compared using sibling-pair linkage analysis. Allelic variation in the genes encoding hepatic lipase and apolipoprotein AI/CIII/AIV accounted for 25 and 22%, respectively, of the total interindividual variation in plasma HDL-C levels. In contrast, none of the variation in plasma HDL-C levels could be accounted for by allelic variation in the cholesteryl ester transfer protein. These findings indicate that a major fraction of the genetically determined variation in plasma HDL-C levels is conferred by allelic variation at the hepatic lipase and the apolipoprotein AI/CIII/AIV gene loci.

Citing Articles

A community based cross sectional study on the prevalence of dyslipidemias and 10 years cardiovascular risk scores in adults in Asmara, Eritrea.

Achila O, Fessahye N, Mengistu S, Habtemikael N, Werke W, Zemichael F Sci Rep. 2022; 12(1):5567.

PMID: 35368036 PMC: 8976836. DOI: 10.1038/s41598-022-09446-9.

Hepatic lipase (LIPC) sequencing in individuals with extremely high and low high-density lipoprotein cholesterol levels.

Pirim D, Bunker C, Hokanson J, Hamman R, Demirci F, Kamboh M PLoS One. 2020; 15(12):e0243919.

PMID: 33326441 PMC: 7743991. DOI: 10.1371/journal.pone.0243919.

The Rise and Fall "ing" of the HDL Hypothesis.

Feghaly J, Mooradian A Drugs. 2020; 80(4):353-362.

PMID: 32020556 DOI: 10.1007/s40265-020-01265-4.

Longitudinal Phenotypes Improve Genotype Association for Hyperketonemia in Dairy Cattle.

Leal Yepes F, Nydam D, Mann S, Caixeta L, McArt J, Overton T Animals (Basel). 2019; 9(12).

PMID: 31805754 PMC: 6941043. DOI: 10.3390/ani9121059.

Prevalence of dyslipidaemia and associated risk factors in a rural population in South-Western Uganda: a community based survey.

Asiki G, Murphy G, Baisley K, Nsubuga R, Karabarinde A, Newton R PLoS One. 2015; 10(5):e0126166.

PMID: 25974077 PMC: 4431752. DOI: 10.1371/journal.pone.0126166.

References

Deeb S, Cheung M, Peng R, Wolf A, Stern R, Albers J . A mutation in the human apolipoprotein A-I gene. Dominant effect on the level and characteristics of plasma high density lipoproteins. J Biol Chem. 1991; 266(21):13654-60. View

Beckmann J, Tomfohrde J, Barnes R, Williams M, Broux O, Richard I . A linkage map of human chromosome 15 with an average resolution of 2 cM and containing 55 polymorphic microsatellites. Hum Mol Genet. 1993; 2(12):2019-30. DOI: 10.1093/hmg/2.12.2019. View

Bhattacharya S, Ameis D, Cullen P, Narcisi T, Bayliss J, Greten H . VNTR polymorphism in the hepatic lipase gene (LIPC). Nucleic Acids Res. 1991; 19(18):5088. PMC: 328828. DOI: 10.1093/nar/19.18.5088-a. View

Steinmetz J, Boerwinkle E, Gueguen R, Visvikis S, Henny J, Siest G . Multivariate genetic analysis of high density lipoprotein particles. Atherosclerosis. 1992; 92(2-3):219-27. DOI: 10.1016/0021-9150(92)90281-k. View

Boerwinkle E, Leffert C, Lin J, Lackner C, Chiesa G, Hobbs H . Apolipoprotein(a) gene accounts for greater than 90% of the variation in plasma lipoprotein(a) concentrations. J Clin Invest. 1992; 90(1):52-60. PMC: 443062. DOI: 10.1172/JCI115855. View

Hudson T, Engelstein M, Lee M, Ho E, Rubenfield M, ADAMS C . Isolation and chromosomal assignment of 100 highly informative human simple sequence repeat polymorphisms. Genomics. 1992; 13(3):622-9. DOI: 10.1016/0888-7543(92)90133-d. View

Wannamethee G, Shaper A . Blood lipids: the relationship with alcohol intake, smoking, and body weight. J Epidemiol Community Health. 1992; 46(3):197-202. PMC: 1059549. DOI: 10.1136/jech.46.3.197. View

Gylling H, Vega G, Grundy S . Physiologic mechanisms for reduced apolipoprotein A-I concentrations associated with low levels of high density lipoprotein cholesterol in patients with normal plasma lipids. J Lipid Res. 1992; 33(10):1527-39. View

Weissenbach J, Gyapay G, Dib C, Vignal A, Morissette J, Millasseau P . A second-generation linkage map of the human genome. Nature. 1992; 359(6398):794-801. DOI: 10.1038/359794a0. View

10.

Hegele R, Little J, Vezina C, Maguire G, Tu L, Wolever T . Hepatic lipase deficiency. Clinical, biochemical, and molecular genetic characteristics. Arterioscler Thromb. 1993; 13(5):720-8. DOI: 10.1161/01.atv.13.5.720. View

11.

Reina M, Deeb S . SSCP polymorphism in the human hepatic triglyceride lipase (LIPC) gene. Hum Mol Genet. 1992; 1(6):453. DOI: 10.1093/hmg/1.6.453-a. View

12.

Shen Y, Thompson A, Holman K, Callen D, Sutherland G, Richards R . Four dinucleotide repeat polymorphisms on human chromosome 16 at D16S289, D16S318, D16S319 and D16S320. Hum Mol Genet. 1992; 1(9):773. DOI: 10.1093/hmg/1.9.773. View

13.

Dammerman M, Sandkuijl L, Halaas J, Chung W, Breslow J . An apolipoprotein CIII haplotype protective against hypertriglyceridemia is specified by promoter and 3' untranslated region polymorphisms. Proc Natl Acad Sci U S A. 1993; 90(10):4562-6. PMC: 46552. DOI: 10.1073/pnas.90.10.4562. View

14.

Xu C, Angelico F, Del Ben M, Humphries S . Role of genetic variation at the apo AI-CIII-AIV gene cluster in determining plasma apo AI levels in boys and girls. Genet Epidemiol. 1993; 10(2):113-22. DOI: 10.1002/gepi.1370100204. View

15.

Blades B, Vega G, Grundy S . Activities of lipoprotein lipase and hepatic triglyceride lipase in postheparin plasma of patients with low concentrations of HDL cholesterol. Arterioscler Thromb. 1993; 13(8):1227-35. DOI: 10.1161/01.atv.13.8.1227. View

16.

Lackner C, Cohen J, Hobbs H . Molecular definition of the extreme size polymorphism in apolipoprotein(a). Hum Mol Genet. 1993; 2(7):933-40. DOI: 10.1093/hmg/2.7.933. View

17.

Haseman J, Elston R . The investigation of linkage between a quantitative trait and a marker locus. Behav Genet. 1972; 2(1):3-19. DOI: 10.1007/BF01066731. View

18.

Miller G, MILLER N . Plasma-high-density-lipoprotein concentration and development of ischaemic heart-disease. Lancet. 1975; 1(7897):16-9. DOI: 10.1016/s0140-6736(75)92376-4. View

19.

Gordon T, CASTELLI W, Hjortland M, Kannel W, DAWBER T . High density lipoprotein as a protective factor against coronary heart disease. The Framingham Study. Am J Med. 1977; 62(5):707-14. DOI: 10.1016/0002-9343(77)90874-9. View

20.

Kuusi T, Saarinen P, NIKKILA E . Evidence for the role of hepatic endothelial lipase in the metabolism of plasma high density lipoprotein2 in man. Atherosclerosis. 1980; 36(4):589-93. DOI: 10.1016/0021-9150(80)90251-8. View